Publications by authors named "M Boes"

Claim this Profile
T
Therapeutic potential of tubular serine protease inhibitors in proteinuria.
Mette Boye Boes, Per Svenningsen, Gitte Rye Hinrichs, Claus Bistrup, Boye Lagerbon Jensen

Am J Physiol Renal Physiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing DC subsets in solid tumors: what about DC3s?
Casper J Pachocki, Marianne Boes, Alsya J Affandi

Immunother Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salivary polyreactive antibodies and are associated with respiratory infection severity in young children with recurrent respiratory infections.
Mischa H Koenen, Wouter A A de Steenhuijsen Piters, Marien I de Jonge, Jeroen D Langereis, Stefan Nierkens, Marianne Boes

Eur Respir J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy.
Chilam Chan, Núria Casalé Cabanes, J H Marco Jansen, Joël Guillaume, Maaike Nederend, Marianne Boes

Cancer Immunol Immunother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells.
A Markovska, K Somers, J Guillaume, J Melief, A P Mazar, M Boes

Sci Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis